JPRN-UMIN000009335已完成未知
A pharmacogenomic study on cisplatin-induced nausea and vomiting.(TRIPLE Pharmacogenomics Study) - TRIPLE Pharmacogenomics Study
Department of Clinical Pharmacology and Genitics, School of Pharmaceutical Science, Univercity of Shizuoka0 个研究点目标入组 200 人开始时间: 2012年11月19日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
尚未招募
Unknown
A study to evaluate cisplatin induced hearing loss among patients of head and neck cancers receiving chemoradiation treatmentCTRI/2024/08/072465Sri Venkateshwara Institute of medical sciences
已完成
不适用
Randomised study of two doses of cisplatin with cyclophosphamide in epithelial ovarian cancerMalignant neoplasm of ovaryOvarian CancerCancerISRCTN78953383Cancer Research UK (CRUK) (UK)
尚未招募
不适用
Comparative response evaluation of Cisplatin-Capecitabine with Cisplatin-5-Fluorouracil in advanced gastric carcinoma.Clinically diagnosed and histopathologically proved advanced gastric carcinoma (AJCC Stage IV).Advanced gastric carcinoma.TCTR20170715001Bangabandhu Sheikh Mujib Medical University62
已完成
3 期
Randomized, comparative clinical study of cisplatin and docetaxel combination chemotherapy and mitomycin, vindesine and cisplatin (MVP) combination chemotherapy with concurrent thoracic radiation therapy for locally advanced unresectable non-small-cell lung cancer (OLCSG0007)inoperable locally advanced non-small-cell lung cancerJPRN-C000000085Okayama Lung Cancer Study Group (OLCSG)200
已完成
2 期
A randomized phase II study comparing cisplatin + docetaxel with carboplatin + paclitaxel in patients with Stage III (N 2 positive) non-small-cell lung cancer who receive trimodality treatment consisting of chemoradiotherapy followed by surgery (OLCSG1601)previously untreated non-small-cell lung ccancer, stage III (N2 positive)JPRN-UMIN000024816Okayama Lung Cancer Study Group (OLCSG)80